Johan Erik Häggblad
Directeur Technique/Scientifique/R&D chez CALLIDITAS THERAPEUTICS AB
Profil
Johan Erik Häggblad is currently working as a Deputy Director at Nefecon AB, Busulipo AB, Pharmalink Nordic AB, Pharmalink Oncology AS, and Epicyt Pharma AB.
He is also serving as the Chief Scientific Officer at Calliditas Therapeutics AB since 2019.
In his former positions, Dr. Häggblad worked as the Chairman at AroCell AB.
He also held Principal positions at Karo Healthcare AB, Pharmacia Corp., and Newron Sweden AB.
Dr. Häggblad obtained his undergraduate and doctorate degrees from the University of Stockholm.
Postes actifs de Johan Erik Häggblad
| Sociétés | Poste | Début |
|---|---|---|
| CALLIDITAS THERAPEUTICS AB | Directeur Technique/Scientifique/R&D | 01/04/2019 |
| Pharmalink Oncology AS | Directeur/Membre du Conseil | - |
Busulipo AB
 Busulipo AB Pharmaceuticals: MajorHealth Technology Busulipo AB is a Swedish company that manufactures and wholesales pharmaceutical and medical technology products. The private company is based in Stockholm, Sweden. | Corporate Officer/Principal | - |
Nefecon AB
 Nefecon AB Pharmaceuticals: MajorHealth Technology Part of Calliditas Therapeutics AB, Nefecon AB is a pharmaceutical company based in Stockholm, Sweden. The Swedish company has developed a patented oral, delayed release formulation of budesonide called nefecon, which is designed to target mucosal B-cells present in the ileum where the disease originates, as per the predominant pathogenesis models. Nefecon is derived from the targit technology, which allows for the substance to pass through the stomach and intestine without being absorbed, and to be released in a pulse-like fashion only when it reaches the lower small intestine. The company has completed a large phase 2b trial, which showed that the combination of dose and optimized release profile is required to be effective in patients with IgA nephropathy. | Corporate Officer/Principal | - |
| Pharmalink Nordic AB | Corporate Officer/Principal | - |
Epicyt Pharma AB
 Epicyt Pharma AB Pharmaceuticals: MajorHealth Technology Epicyt Pharma AB is a Swedish pharmaceutical research company that was founded in 2016 by Ville Wallenius and Lars Fändriks. The company is based in Mölndal, Sweden. Epicyt Pharma develops the drug candidate BAFA. | Directeur/Membre du Conseil | - |
Anciens postes connus de Johan Erik Häggblad
| Sociétés | Poste | Fin |
|---|---|---|
Newron Sweden AB
 Newron Sweden AB Pharmaceuticals: MajorHealth Technology Newron Sweden AB is a biopharmaceutical company engaged in the development of novel therapies for the treatment of disorders of the central nervous systems. The company was founded by Jonas Cristopher Frisen and Ann Marie Janson in 1998 and is headquartered in Stockholm, Sweden. | Corporate Officer/Principal | 01/01/2007 |
Pharmacia Corp.
 Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Pharmacia Corp. developed, manufactured and marketed pharmaceutical products. Prescription pharmaceuticals included general therapeutics, ophthalmology and hospital products including oncology and diversified therapeutics. It also operated in consumer health care, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The customers of the group were pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. It was headquartered in Peapack, NJ. | Corporate Officer/Principal | 01/01/2001 |
| KARO PHARMA AB (PUBL) | Corporate Officer/Principal | 01/01/1997 |
| ░░░░░░░ ░░ | ░░░░░░░░░░ | - |
Formation de Johan Erik Häggblad
| University of Stockholm | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| CALLIDITAS THERAPEUTICS AB | Health Technology |
| KARO PHARMA AB (PUBL) | Health Technology |
| AROCELL AB | Health Technology |
| Entreprise privées | 7 |
|---|---|
Pharmacia Corp.
Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Pharmacia Corp. developed, manufactured and marketed pharmaceutical products. Prescription pharmaceuticals included general therapeutics, ophthalmology and hospital products including oncology and diversified therapeutics. It also operated in consumer health care, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The customers of the group were pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. It was headquartered in Peapack, NJ. | Health Technology |
Newron Sweden AB
Newron Sweden AB Pharmaceuticals: MajorHealth Technology Newron Sweden AB is a biopharmaceutical company engaged in the development of novel therapies for the treatment of disorders of the central nervous systems. The company was founded by Jonas Cristopher Frisen and Ann Marie Janson in 1998 and is headquartered in Stockholm, Sweden. | Health Technology |
| Pharmalink Oncology AS | |
Busulipo AB
Busulipo AB Pharmaceuticals: MajorHealth Technology Busulipo AB is a Swedish company that manufactures and wholesales pharmaceutical and medical technology products. The private company is based in Stockholm, Sweden. | Health Technology |
Nefecon AB
Nefecon AB Pharmaceuticals: MajorHealth Technology Part of Calliditas Therapeutics AB, Nefecon AB is a pharmaceutical company based in Stockholm, Sweden. The Swedish company has developed a patented oral, delayed release formulation of budesonide called nefecon, which is designed to target mucosal B-cells present in the ileum where the disease originates, as per the predominant pathogenesis models. Nefecon is derived from the targit technology, which allows for the substance to pass through the stomach and intestine without being absorbed, and to be released in a pulse-like fashion only when it reaches the lower small intestine. The company has completed a large phase 2b trial, which showed that the combination of dose and optimized release profile is required to be effective in patients with IgA nephropathy. | Health Technology |
| Pharmalink Nordic AB | |
Epicyt Pharma AB
Epicyt Pharma AB Pharmaceuticals: MajorHealth Technology Epicyt Pharma AB is a Swedish pharmaceutical research company that was founded in 2016 by Ville Wallenius and Lars Fändriks. The company is based in Mölndal, Sweden. Epicyt Pharma develops the drug candidate BAFA. | Health Technology |